secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001104659-24-079854
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone adds two directors, plans third under agreement with Alta activist investor
--------------------------------------------------------------------------------

- Appointed Stuart Duty and Andrew Saik as independent directors effective July 14, 2024.
- Cooperation agreement: Alta withdraws director nominations; Milestone to appoint third mutually agreeable independent by Sept 6, 2024.
- Directors Debra Liebert and Richard Pasternak will not stand for reelection (no disagreement).
- Alta agrees to standstill and vote with board recommendations until after 2025 annual meeting.
- Board size to rise to nine then reduce to eight after 2024 meeting and third appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465924079854/0001104659-24-079854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465924079854/tm2419444d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-079854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer